Matauro LLC acquired a new position in Colgate-Palmolive (NYSE:CL – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 9,113 shares of the company’s stock, valued at approximately $828,000.
Other hedge funds have also recently made changes to their positions in the company. Chicago Partners Investment Group LLC grew its stake in shares of Colgate-Palmolive by 16.2% in the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after buying an additional 943 shares during the period. Peak Financial Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $1,315,000. Gordian Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at about $602,000. Carrera Capital Advisors grew its stake in shares of Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after buying an additional 7,353 shares during the period. Finally, Fiduciary Alliance LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $4,066,000. 80.41% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of research firms have issued reports on CL. Wells Fargo & Company cut their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Raymond James reiterated an “outperform” rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Finally, Stifel Nicolaus cut their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $101.16.
Colgate-Palmolive Stock Up 1.9 %
CL opened at $89.56 on Friday. The company has a fifty day moving average price of $88.94 and a 200-day moving average price of $95.91. The firm has a market capitalization of $72.68 billion, a P/E ratio of 25.44, a price-to-earnings-growth ratio of 4.18 and a beta of 0.44. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a one year low of $84.45 and a one year high of $109.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the company posted $0.87 earnings per share. Equities research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a $0.50 dividend. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.23%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- 10 Best Airline Stocks to Buy
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- What Are Some of the Best Large-Cap Stocks to Buy?
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.